公开(公告)号：US20230227435A1

公开(公告)日：2023-07-20

申请号：US18002080

申请日：2021-06-17

Applicant: LEO PHARMA A/S

Inventor： Mark ANDREWS ,  Kevin Neil DACK ,  Jimmi Gerner SEITZBERG ,  Peter ANDERSEN

IPC: C07D403/12 ,  C07D401/14 ,  C07D403/14 ,  C07D413/14 ,  C07D405/14

CPC classification number: C07D403/12 ,  C07D401/14 ,  C07D403/14 ,  C07D413/14 ,  C07D405/14

Abstract: The present disclosure relates to compounds according to formula I






and pharmaceutically acceptable salts, hydrates, or solvates thereof. The disclosure further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.